Niche PTs on a Biennial/Triennial Schedule: Seize the Opportunities of 2026

Molecules under study: erythromycin, josamycin, lincomycin, oleandamycin, rifampicin, spiramycin, tilmicosin, tylosin A, tylosin B, total tylosin, virginiamycin, pirlimycin.
THE PRESENCE OF LINCOMYCIN IS GUARANTEED!

PT for NITROFURAN METABOLITES in SWINE MUSCLE


(code M6103) – ROUND of MARCH 2026

PT for NITROFURAN METABOLITES in SHRIMPS

(code SF6104) – ROUND of SEPTEMBER 2026

Molecules under study: AOZ, AMOZ, SEM, AHD, DNSH
3 MOLECULES WILL BE PRESENT. THE PRESENCE OF DNSH IS GUARANTEED.

Molecules under study: dimetridazole, metronidazole, ipronidazole, ronidazole, 2-Hydroxy Dimetridazole (HMMNI), 2-Hydroxy Metronidazole, 2-Hydroxy Ipronidazole

More than 60 molecules under study: the complete list of molecules under study can be found in the commercial program (page 28).
AT LEAST 6 MOLECULES WILL BE PRESENT.